172 related articles for article (PubMed ID: 12417046)
1. Development of gene therapy using prostate-specific membrane antigen promoter/enhancer with Cre Recombinase/LoxP system for prostate cancer cells under androgen ablation condition.
Ikegami S; Tadakuma T; Suzuki S; Yoshimura I; Asano T; Hayakawa M
Jpn J Cancer Res; 2002 Oct; 93(10):1154-63. PubMed ID: 12417046
[TBL] [Abstract][Full Text] [Related]
2. Treatment efficiency of a suicide gene therapy using prostate-specific membrane antigen promoter/enhancer in a castrated mouse model of prostate cancer.
Ikegami S; Tadakuma T; Ono T; Suzuki S; Yoshimura I; Asano T; Hayakawa M
Cancer Sci; 2004 Apr; 95(4):367-70. PubMed ID: 15072597
[TBL] [Abstract][Full Text] [Related]
3. Two-step transcriptional amplification-lipid-based nanoparticles using PSMA or midkine promoter for suicide gene therapy in prostate cancer.
Hattori Y; Maitani Y
Cancer Sci; 2006 Aug; 97(8):787-98. PubMed ID: 16800821
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus mediated prostate specific enzyme prodrug gene therapy using prostate specific antigen promoter enhanced by the Cre-loxP system.
Yoshimura I; Ikegami S; Suzuki S; Tadakuma T; Hayakawa M
J Urol; 2002 Dec; 168(6):2659-64. PubMed ID: 12442005
[TBL] [Abstract][Full Text] [Related]
5. Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer.
Kijima T; Osaki T; Nishino K; Kumagai T; Funakoshi T; Goto H; Tachibana I; Tanio Y; Kishimoto T
Cancer Res; 1999 Oct; 59(19):4906-11. PubMed ID: 10519403
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific suicide gene therapy using the prostate-specific membrane antigen promoter and enhancer.
O'Keefe DS; Uchida A; Bacich DJ; Watt FB; Martorana A; Molloy PL; Heston WD
Prostate; 2000 Oct; 45(2):149-57. PubMed ID: 11027414
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy utilizing the Cre/loxP system selectively suppresses tumor growth of disseminated carcinoembryonic antigen-producing cancer cells.
Goto H; Osaki T; Kijima T; Nishino K; Kumagai T; Funakoshi T; Kimura H; Takeda Y; Yoneda T; Tachibana I; Hayashi S
Int J Cancer; 2001 Nov; 94(3):414-9. PubMed ID: 11745423
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of prostate specific membrane antigen/folate hydrolase transcription by an enhancer.
Noss KR; Wolfe SA; Grimes SR
Gene; 2002 Feb; 285(1-2):247-56. PubMed ID: 12039052
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated suicide-gene therapy using the herpes simplex virus thymidine kinase gene in cell and animal models of human prostate cancer: changes in tumour cell proliferative activity.
Cheon J; Kim HK; Moon DG; Yoon DK; Cho JH; Koh SK
BJU Int; 2000 Apr; 85(6):759-66. PubMed ID: 10759680
[TBL] [Abstract][Full Text] [Related]
10. Suicide gene therapy on LNCaP human prostate cancer cells.
Yoshimura I; Suzuki S; Tadakuma T; Hayakawa M
Int J Urol; 2001 Jul; 8(7):S5-8. PubMed ID: 11442669
[TBL] [Abstract][Full Text] [Related]
11. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for prostate cancer by controlling adenovirus E1a and E4 gene expression with PSES enhancer.
Li X; Zhang YP; Kim HS; Bae KH; Stantz KM; Lee SJ; Jung C; Jiménez JA; Gardner TA; Jeng MH; Kao C
Cancer Res; 2005 Mar; 65(5):1941-51. PubMed ID: 15753394
[TBL] [Abstract][Full Text] [Related]
13. Specific targeting of prostate cancer cells in vitro by the suicide gene/prodrug system, uracil phosphoribosyltransferase/5-fluorouracil, under the control of prostate-specific membrane antigen promoter/enhancer.
Zhao FJ; Zhang S; Yu ZM; Xia SJ; Li H
Prostate Cancer Prostatic Dis; 2009; 12(2):166-71. PubMed ID: 18626508
[TBL] [Abstract][Full Text] [Related]
14. Coexpression of the partial androgen receptor enhances the efficacy of prostate-specific antigen promoter-driven suicide gene therapy for prostate cancer cells at low testosterone concentrations.
Suzuki S; Tadakuma T; Asano T; Hayakawa M
Cancer Res; 2001 Feb; 61(4):1276-9. PubMed ID: 11245419
[TBL] [Abstract][Full Text] [Related]
15. In vivo suicide gene therapy model using a newly discovered prostate-specific membrane antigen promoter/enhancer: a potential alternative approach to androgen deprivation therapy.
Uchida A; O'Keefe DS; Bacich DJ; Molloy PL; Heston WD
Urology; 2001 Aug; 58(2 Suppl 1):132-9. PubMed ID: 11502468
[TBL] [Abstract][Full Text] [Related]
16. Liposome-mediated gene therapy using HSV-TK/ganciclovir under the control of human PSA promoter in prostate cancer cells.
Suzuki S; Tadakuma T; Kunitomi M; Takayama E; Sato M; Asano T; Nakamura H; Hayakawa M
Urol Int; 2001; 67(3):216-23. PubMed ID: 11598449
[TBL] [Abstract][Full Text] [Related]
17. Using HSV-TK/GCV suicide gene therapy to inhibit lens epithelial cell proliferation for treatment of posterior capsular opacification.
Jiang YX; Lu Y; Liu TJ; Yang J; Chen Y; Fang YW
Mol Vis; 2011 Jan; 17():291-9. PubMed ID: 21283526
[TBL] [Abstract][Full Text] [Related]
18. Double-targeted and double-enhanced suicide gene therapy mediated by generation 5 polyamidoamine dendrimers for prostate cancer.
Chen Y; Wang G; Kong D; Zhang Z; Yang K; Liu R; Zhao W; Xu Y
Mol Carcinog; 2013 Mar; 52(3):237-46. PubMed ID: 22161782
[TBL] [Abstract][Full Text] [Related]
19. Recombinant adenovirus mediated prostate-specific enzyme pro-drug gene therapy regulated by prostate-specific membrane antigen (PSMA) enhancer/promoter.
Zeng H; Wei Q; Huang R; Chen N; Dong Q; Yang Y; Zhou Q
J Androl; 2007; 28(6):827-35. PubMed ID: 17522418
[TBL] [Abstract][Full Text] [Related]
20. Enhanced combined tumor-specific oncolysis and suicide gene therapy for prostate cancer using M6 promoter.
Ahn M; Lee SJ; Li X; Jiménez JA; Zhang YP; Bae KH; Mohammadi Y; Kao C; Gardner TA
Cancer Gene Ther; 2009 Jan; 16(1):73-82. PubMed ID: 18772902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
